{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:36:53Z","timestamp":1790289413734,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>To review the efficacy and safety of oral doxycycline antibiotics versus macrolides in the treatment of meibomian gland dysfunction (MGD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Systematic review and meta\u2010analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a systematic search of electronic databases for all peer\u2010reviewed published studies which included clinical outcomes of oral antibiotic MGD treatment. Individual study data were extracted and evaluated in a weighted pooled analysis, including total sign and symptom scores, meibomian gland secretion score, tear break\u2010up time (TBUT), fluorescein staining score and rate of complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two thousand nine hundred and thirty\u2010three studies were found, of which 54 were eligible for the systematic review, and six prospective studies were ultimately included for analysis, reporting on 563 cases from three countries. Age of affected patients ranged between 12 and 90\u2009years. Overall, both treatment methods induced improvement in MGD signs and symptoms. In pooled analysis, macrolides were significantly superior in the total signs score (pooled standardized mean difference (SMD) \u22120.51, 95% confidence interval (CI): \u22120.99 to \u22120.03), meibomian gland secretion score (pooled SMD \u22120.25, 95%CI: [\u22120.48, \u22120.03]), TBUT (SMD \u22120.31, 95%CI: [\u22120.50, \u22120.13]) and fluorescein staining score (SMD \u22121.01, 95%CI: [\u22121.72, \u22120.29]). Moreover, while no severe complications were reported for both treatments, the macrolide group exhibited significantly less adverse events (pooled odds ratio 0.24 with a 95% CI of 0.16 to 0.34).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both macrolides and tetracyclines are effective treatments for MGD. In this study, macrolides exhibited better efficacy and safety profile compared to tetracyclines.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aos.15681","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T09:15:04Z","timestamp":1683191704000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic antibiotic treatment for meibomian gland dysfunction\u2014A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"102","author":[{"given":"Dror","family":"Ben\u00a0Ephraim\u00a0Noyman","sequence":"first","affiliation":[{"name":"Ophthalmology Department Rambam Health Care Campus  Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara C.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-0993","authenticated-orcid":false,"given":"Michael","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Ophthalmology Department Rambam Health Care Campus  Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1814-8316","authenticated-orcid":false,"given":"Margarita","family":"Safir","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Yitzhak Shamir Medical Center, Sackler Faculty of Medicine Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.10.019"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.091579"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/01632780122034885"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.05.031"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2017.10.050"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.08.003"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1244_17"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(82)90365-8"},{"key":"e_1_2_6_10_1","first-page":"1481","article-title":"Oral azithromycin versus doxycyclin for the treatment of moderate to severe meibomian gland dysfunction (MGD): a randomized prospective non\u2010inferiority study","volume":"55","author":"Heitz A.","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/2515841418783622"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305410"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000235550"},{"key":"e_1_2_6_14_1","first-page":"107","article-title":"Observational comparative study to evaluate the efficacy of oral azithromycin and oral doxycycline in management of meibomian gland dysfunction","volume":"3","author":"Kothari R.","year":"2017","journal-title":"Indian Journal of Clinical and Experimental Ophthalmology"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.06.009"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2014.02.014"},{"key":"e_1_2_6_18_1","first-page":"407","article-title":"Comparative study to evaluate the efficacy of oral azithromycin and oral doxycycline in refractory meibomian gland dysfunction","volume":"9","author":"Malik D.K.C.","year":"2022","journal-title":"European Journal of Molecular & Clinical Medicine"},{"issue":"8","key":"e_1_2_6_19_1","first-page":"222","article-title":"A comparative study between oral azithromycin and doxycycline for the treatment of Meibomian gland dysfunction","volume":"14","author":"Manoj Kumar Mishra V.K.","year":"2022","journal-title":"International Journal of Pharmaceutical and Clinical Research"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13224"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997b"},{"key":"e_1_2_6_22_1","article-title":"Oral antibiotics for chronic blepharitis","volume":"6","author":"Onghanseng N.","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch13"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6997e"},{"issue":"1","key":"e_1_2_6_25_1","first-page":"86","article-title":"A comparative study between the efficacy of oral azithromycin versus the efficacy of oral doxycycline over 6 months in patients of Meibomian gland dysfunction","volume":"8","author":"Singh H.","year":"2022","journal-title":"International Journal of Medical Research Professionals"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.133900"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0876-2"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.10.062"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2005.19.4.258"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002447"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-009-1603-x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.15681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T05:42:52Z","timestamp":1705556572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.15681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1111\/aos.15681"],"URL":"https:\/\/doi.org\/10.1111\/aos.15681","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"2023-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}